POULTRY VACCINE MARKET ANALYSIS

The global poultry vaccine market was valued at US$ 1,766.8 Mn in 2022 and is forecast to reach a value of US$ 3,240.2 Mn by 2030 at a CAGR of 7.9% between 2023 and 2030. The global poultry vaccine market is experiencing strong growth due to the increase in incidence of zoonotic diseases and increasing poultry population around the world. Furthermore, rise in demand for safe and effective poultry vaccine and favorable initiatives taken by several government agencies and animal associations is expected to boost growth of the market. However, factors such as high cost of poultry vaccine and use of counterfeit products are expected to hamper the market growth.

Global Poultry Vaccine Market: Regional Insights

Based on geography, the global poultry vaccine market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the increasing incidences of zoonotic diseases and favorable initiatives taken by government agencies and animal associations in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), zoonotic diseases are common in the U.S. More than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals. Thus, CDC works 24/7 to protect people from zoonotic diseases in the U.S.

Asia Pacific is also expected to witness robust growth in the global poultry vaccine market due to the rising incidence of diseases in poultry, increasing demand to secure food sources, and favorable initiatives taken by government in this region. For instance, according to the National Centre for Disease Control (NCDC), more than 75% of emerging and re-emerging infections are zoonotic, and new pathogens (viruses) continue to emerge and spread across countries. some of the zoonotic diseases which are prevalent in India are Rabies, Brucellosis, Cysticercosis, Japanese Encephalitis (JE), Echinococcosis, Plague, Leptospirosis, Nipah, Scrub typus, Toxoplasmosis, Kyasanur forest disease (KFD), Trypanosomiasis, and Crimean-Congo haemorrhagic fever (CCHF).

Figure 1. Global Poultry Vaccine Market Share (%), by Region, 2023

To learn more about this report, request sample copy

Global Poultry Vaccine Market Drivers:

Rise in burden of zoonotic diseases to drive market growth

One of the key factors expected to augment the growth of the global poultry vaccine market during the forecast period is the rise in incidence of zoonotic diseases worldwide. For instance, zoonoses comprise a large percentage of all newly identified infectious diseases and many existing ones. According to the World Health Organization (WHO), there are over 150 zoonotic diseases around the world, which are transmitted to humans by both wild and domestic animal populations, 13 of which are responsible for 2.2 million deaths per year. This in turn is expected to increase demand for poultry vaccine, driving the growth of the market.

Growing poultry population to propel market growth

Another factor which is driving the growth of the global poultry vaccine market is the increasing poultry population around the world. With the increase in poultry population, the risk of zoonotic diseases as well as the demand for safe and effective poultry vaccine is also increasing rapidly. For instance, the number of chickens worldwide has more than doubled since 1990, according to the Food and Agriculture Organization (FAO) of the United Nations. The number of chickens, which was 14.38 billion in 2000, reached 25.9 billion in 2019. The largest share of this presence belongs to Asian countries. This in turn is also driving the market growth.

Global Poultry Vaccine Market Opportunities:

Increase in demand for safe/effective poultry vaccine worldwide is expected to provide significant growth opportunities for players in the poultry vaccine market. For instance, with the increase in prevalence or incidence of poultry and zoonotic diseases, the demand for safe and effective vaccine is also increasing worldwide. In December 2022, Hester Biosciences signed an agreement to obtain indigenous technology, to develop and commercialize a poultry vaccine to prevent low pathogenic avian influenza. Hester acquired the technology from Indian Council of Agricultural Research-National Institute of High Security Animal Diseases (ICAR-NIHSAD).

Favorable initiatives taken by government agencies and animal associations is expected to provide significant growth opportunities for players in the global poultry vaccine market. For instance, The World Health Organization (WHO) has identified Antimicrobial resistance as public health threat. Many public health bodies and veterinary regulatory agencies such as the Committee for Medicinal Products for Veterinary Use (CVMP) are responsible for implementing the European Union’s One Health Action Plan against antimicrobial resistance by deploying several policies of the Veterinary Medicines Regulation. This in turn is driving the market growth.

Global Poultry Vaccine Market Trends:

Rise in focus on vaccine development is a recent trend

Over the years, the poultry vaccines market has evolved rapidly, in terms of product development. Players in the market as well as researchers and new vaccine companies are focusing on developing and launching safe and effective vaccines in the market. Researchers at the Pirbright Institute, have developed a new method of the genetically-modified vaccines to protect against infectious bursal disease (IBD), avian influenza, and Newcastle disease. This trend is expected to continue over the forecast period, driving the growth of the market.

Increase in use of biotechnologies is another trend

The poultry industry has leveraged biotechnologies to improve the safety and convenience of avian vaccination. The vector technology scheme/plan is expected to play an important role in delivering the active component of the vaccine to the animal. For instance, Merial's VAXXITEK HVT + IBD is one of the leading vector vaccines, available in about 75 countries, worldwide. The development of new technologies will stimulate development of improved products to protect against dangerous strains of the virus. This trend is also expected to continue during the forecast period.

Global Poultry Vaccine Market Restraints:

High cost of poultry vaccine to hinder market growth

One of the key factors expected to hamper growth of the global poultry vaccine market is the high cost of animal testing and veterinary services. Costs associated with vaccination have increased, as many indirect costs are associated with the vaccine production, which include personnel costs for placing orders, inventory, insurance against loss of the vaccines, recovery of costs attributable to inventory shrinkage, wastage, non-payment, and lost opportunity cost. Moreover, vaccines that are wasted due to equipment failures add up to a significant monetary and public health cost.

Use of counterfeit medicine to hamper market growth

Another factor which is hampering the growth of the global poultry vaccine market is the usage of counterfeit medicine. According to National Institute of Standards and Technology (NIST), around 35% of vaccines lost their potencies during their shipping around the world, as they were stored at temperatures, which were either too high or low. The cost of vaccine handling has also increased due to stringent guidelines, which is acting as a major barrier for the market growth. However, this in turn has increased the use of counterfeit products/medicine.

Figure 2. Global Poultry Vaccine Market Share (%), by Disease, 2023

To learn more about this report, request sample copy

Global Poultry Vaccine Market Segmentation:

The global poultry vaccine market report is segmented into Disease, Technology, and Geography.

Based on Disease, the market is segmented into Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Other Diseases. Out of which, Bronchitis Segment is expected to dominate the poultry vaccine market over the forecast period and this is attributed to the increase in burden of bronchitis. Infectious bronchitis is a common highly contagious disease that affects the poultry animals. It is a very common disease and has high morbidity.

Avian Influenza Segment is also expected to witness robust growth in the near future and this is owing to the increase in burden of avian diseases. Avian influenza or bird flu refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses.

Based on Technology, the poultry vaccine market is segmented into Live Attenuated Vaccines (LAV), Recombinant Vaccines, Inactivated Vaccines, and Other Technologies. Out of which, Live Attenuated Vaccines (LAV) Segment is expected to dominate the market over the forecast period and this is attributed to the increase in usage of live attenuated vaccines. Live attenuated vaccines (LAV) are being widely applied to vaccination programs.

Recombinant Vaccines Segment is also expected to witness significant growth in the near future and this is owing to the increase in demand for recombinant vaccines. Recombinant viruses were employed as bivalent, live-virus vaccines to immunize chickens against avian influenza.

Global Poultry Vaccine Market: Key Developments

In October 2022, Zoetis expanded its poultry vaccine portfolio with the introduction of Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early/robust protection against Marek’s, infectious bursal and Newcastle disease viruses with one dose.

In April 2022, Elanco, in collaboration with Ginkgo Bioworks, launched a new animal healthcare company called BiomEdit to develop drugs, nutritional products, and disease-monitoring methods for livestock. The new firm hopes to address antibiotic resistance and improve sustainability.

In January 2020, Boehringer Ingelheim announced the launch of the VAXXITEK HVT+IBD+ND vaccine to protect poultry against various diseases, such as Newcastle Disease, Marek’s Disease, and Infectious Bursal Disease (classic and variant types).

In September 2019, Boehringer Ingelheim started developing the largest biotechnology production sites for veterinary vaccines in Europe, building on France’s pioneering expertise in the veterinary public health (VPH). The company will invest 200 million euro into this high-tech complex.

Global Poultry Vaccine Market: Key Companies Insights

The global poultry vaccine market is highly competitive. This is attributed to the rise in demand for safe & effective poultry vaccine across the globe, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global poultry vaccine market are Zoetis Inc., Merck & Co. Inc., Elanco, Ceva Santé Animale, Boehringer Ingelheim, Biovac, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Venky’s Limited, and Phibro Animal Health Corporation, among others.

*Definition: Vaccines help to prevent any particular disease by boosting the bird’s immune system to produce antibodies, which in turn, fight against a variety of organisms and diseases. A poultry vaccine help bird develop immunity to pathogens and protect them against a disease.